Rifaximin-treatment of Collagenous Colitis

NCT03658993 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

50

Enrollment

INDIV

Sponsor class

Conditions

Collagenous Colitis

Interventions

DRUG: Rifaximin 550 MG

Sponsor

Bonderup, Ole K., M.D.